When will bimatoprost .01 generic be approved in the us?

I can’t tell you an exact approval date for a specific “bimatoprost .01% generic” without knowing which product/ANDA you mean, because FDA approvals depend on the specific application, patent/exclusivity status, and review timeline.

That said, here’s the fastest way to get a reliable answer:

1. Check FDA’s Orange Book

   • Go to: https://www.accessdata.fda.gov/scripts/cder/daf/
   • Search: bimatoprost 0.01% (and/or the brand name it references—commonly Lumigan).
   • Look for the generic applicants and any fields like “Approval Date” and “Patent/Exclusivity Expiration.”

2. Check FDA’s ANDA status / approval history

   • If an ANDA was approved but not yet marketed widely, you’ll see the approval date in the Orange Book and sometimes later commercial availability.

If you tell me either:

• the brand name you’re referring to (e.g., Lumigan and the formulation: solution/concentration), and/or
• the manufacturer/applicant name (from the listing),

…I can help you interpret the Orange Book data and give you the most likely “when” based on existing approvals and exclusivity/patent barriers.